Skip to content

To compare the effectiveness of fentanyl when used alongside bupivacaine and ropivacaine for postoperative pain relief in lower limb orthopedic surgeries.

COMPARISION OF EFFICACY OF INTRATHECAL FENTANYL AS AN ADJUVANT TO BUPIVACAINE AND ROPIVACAINE IN LOWER LIMB ORTHOPAEDIC SURGERIES FOR POST OPERATIVE ANALGESIA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054792
Enrollment
66
Registered
2023-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Fentanyl in bupivacaine: 25 micrograms fentanyl will be added as adjuvant to bupivacaine for spinal anaesthesia for lower limb orthopaedic surgeries Control Intervention1: Fentanyl in R

Sponsors

ACHARYA VINOBHA BHAVE RURAL HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study Patients in ASA Grade I & II Patients willing to give written informed consent

Exclusion criteria

Exclusion criteria: Patientâ??s refusal to participate in the study. Patients with haemorrhagic diathesis. ASA Grade III and above Patients having allergy to test drug Patients with significant scoliosis or kyphosis Pregnant patients

Design outcomes

Primary

MeasureTime frame
comparision of post operative analgesia in patients receiving bupivacaine with fentanyl and Ropivacaine with fentanyl in lower limb orthopaedic surgeries via Sub arachnoid blockTimepoint: Postoperative 24 hours

Secondary

MeasureTime frame
comparision of haemodynamic parameters & side effects if anyTimepoint: post operative 2 hours

Countries

India

Contacts

Public ContactSHYAMOLIMA BHUYAN

DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH

doctorchandak@gmail.com9422903551

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026